Kymera Therapeutics Inc. Common Stock vs The Magnum Ice Cream Company N.V. Ordinary Shares — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.81 (market cap $8.88B), while The Magnum Ice Cream Company N.V. Ordinary Shares trades at $18.49 (market cap $10.98B). The key difference: The Magnum Ice Cream Company N.V. Ordinary Shares is the larger of the two by market cap, and The Magnum Ice Cream Company N.V. Ordinary Shares is more actively traded (789,308 versus 1,028,790). Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and The Magnum Ice Cream Company N.V. Ordinary Shares for 0 Days on average.
| KYMR | MICC | |
|---|---|---|
Market Cap | $8.88B | $10.98B |
Volume | 1,028,790 | 789,308 |
Sector | Health | Consumer Staples |
52-Week High | $127.31 | $20.42 |
52-Week Low | $55.80 | $13.06 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $8.27B | $14.41B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →The Magnum Ice Cream Company N.V. manufactures and sells ice cream and frozen desserts through brands including Magnum, Ben & Jerry's, Wall's, and Cornetto, distributing across roughly 80 countries.
Read more on MICC →